Laboratories & Research
XiltriX plays an important role in your research protocol. Clinical research requires management and control of the study and fully backed up by reports and documentation. XiltriX offers data protection with multiple data back-up, document control and key data of your Scientific processes for your statistical review. XiltriX provides data on all procedures and processes for complete traceability right from the beginning of your research. Measuring all devices involved in the project as well as environmental parameters. Full documentation is provided and outlines how your data was created, the context of the data, its structure and contents.
Time = Money
From a perspective of quality, having a complete Monitoring & Alarm Solution is a no brainer. Why then do fewer than expected labs invest in a proper solution. Most money is poured into research equipment, people and disposables to push research forward as fast as possible. This is an understandable choice, because no researcher wants to be second in publishing data. But publishing data is not the end. If the samples with which the data was created. If these samples are lost because of a freezer malfunction, the results are no longer valid, because they can no longer be reproduced. Having a proper fail-safe in place therefore is invaluable for any research organization.
Clinical Trials
Some laboratories do not have to adhere to the most stringent accreditations, but have sponsors that they perform Clinical Trials with. These sponsors will set rigorous rules to the way the performance of the devices used (for example all fridges and freezers) are controlled. If anything goes wrong with these devices, or there is no measurement data for these devices longer even then 30 minutes, products have to be discarded, inevitably delaying the Clinical Trial. Having a real-time monitoring system like XiltriX working in the background will take away this risk and provide all the requested traceability.
If you would like to know more about XiltriX, let me know.
Han Weerdesteyn
CCO